Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong
· Delayed Price · Currency is HKD
Full Chart
Watchlist
Alerts
Compare
7.54
-0.60 (-7.37%)
Jun 18, 2026, 4:08 PM HKT
Overview
Financials
Forecast
Statistics
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
Annual
Semi-Annual
TTM
HKG:2591 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
FY 2023
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Cash & Equivalents
969.09
526.51
157.64
Short-Term Investments
105.43
45.15
42.55
Trading Asset Securities
130
225.19
495.13
Cash & Short-Term Investments
1,205
796.85
695.31
Cash Growth
51.16%
14.60%
-
Accounts Receivable
5.56
-
-
Other Receivables
137.33
7.73
1.34
Receivables
142.88
7.73
1.34
Inventory
115.94
29.04
3.45
Other Current Assets
15.64
5.6
257.38
Total Current Assets
1,479
839.22
957.48
Property, Plant & Equipment
35.18
13.3
54.85
Other Intangible Assets
21.58
24.09
35.87
Other Long-Term Assets
35.27
58.19
57.17
Total Assets
1,571
934.8
1,105
Accounts Payable
225.08
91.05
88.33
Accrued Expenses
86.87
29.95
14.51
Short-Term Debt
150.26
9.9
1
Current Portion of Leases
3.04
-
4.82
Current Unearned Revenue
-
1
-
Other Current Liabilities
39.34
6.37
250.74
Total Current Liabilities
504.58
138.26
359.4
Long-Term Leases
12.96
-
40.76
Other Long-Term Liabilities
0.07
0.07
0.07
Total Liabilities
517.61
138.33
400.24
Common Stock
456.82
420.26
397.67
Additional Paid-In Capital
1,811
1,264
1,037
Retained Earnings
-1,839
-1,497
-1,323
Comprehensive Income & Other
623.8
609.28
593.24
Shareholders' Equity
1,053
796.47
705.13
Total Liabilities & Equity
1,571
934.8
1,105
Total Debt
166.26
9.9
46.59
Net Cash (Debt)
1,038
786.95
648.73
Net Cash Growth
31.94%
21.31%
-
Net Cash Per Share
2.39
1.88
1.69
Filing Date Shares Outstanding
456.82
420.26
382.8
Total Common Shares Outstanding
456.82
420.26
382.8
Working Capital
974.4
700.96
598.07
Book Value Per Share
2.31
1.90
1.84
Tangible Book Value
1,032
772.38
669.26
Tangible Book Value Per Share
2.26
1.84
1.75
Machinery
28.08
24.56
22.43
Construction In Progress
0.52
-
4.45
Leasehold Improvements
5.48
0.15
-